Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from IVD Medical Holding Limited ( (HK:1931) ).
ETHK Labs Inc. has announced the current composition of its board of directors and the allocation of roles across key board committees, formalizing its governance framework for investors and stakeholders. The board consists of two executive directors, two non-executive directors and three independent non-executive directors, with independent director Zhang Jianlei appointed as chairman of the audit, remuneration and nomination committees, and other independent directors serving as members, underscoring an emphasis on independent oversight and alignment with corporate governance best practices in the Hong Kong market.
The most recent analyst rating on (HK:1931) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on IVD Medical Holding Limited stock, see the HK:1931 Stock Forecast page.
More about IVD Medical Holding Limited
ETHK Labs Inc., incorporated in the Cayman Islands and listed in Hong Kong under stock code 1931, operates with a board comprising executive, non-executive and independent non-executive directors, reflecting a typical governance structure for a publicly traded company in the region. The company’s leadership includes a general manager among its executive directors and relies on board committees to oversee key areas such as audit, remuneration and nominations in line with market expectations for corporate governance standards.
Average Trading Volume: 2,707,640
Technical Sentiment Signal: Sell
Current Market Cap: HK$3.78B
For an in-depth examination of 1931 stock, go to TipRanks’ Overview page.